Published in J Clin Microbiol on January 16, 2008
Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2. PLoS Pathog (2011) 1.62
Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One (2011) 1.57
Routine identification of medical fungi by the new Vitek MS matrix-assisted laser desorption ionization-time of flight system with a new time-effective strategy. J Clin Microbiol (2012) 1.52
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol (2012) 1.28
Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J Clin Microbiol (2009) 1.21
Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J Clin Microbiol (2010) 1.20
Fungal sex and pathogenesis. Clin Microbiol Rev (2010) 1.16
Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts. PLoS One (2014) 1.14
Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates. J Clin Microbiol (2008) 1.10
Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol (2008) 1.10
Rapid molecular identification of pathogenic yeasts by pyrosequencing analysis of 35 nucleotides of internal transcribed spacer 2. J Clin Microbiol (2010) 1.02
Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis. J Clin Microbiol (2009) 0.95
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients. Infect Drug Resist (2012) 0.93
Comparative genomics of emerging pathogens in the Candida glabrata clade. BMC Genomics (2013) 0.92
Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom. J Clin Microbiol (2013) 0.92
Rapid discrimination between Candida glabrata, Candida nivariensis, and Candida bracarensis by use of a singleplex PCR. J Clin Microbiol (2011) 0.90
Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods. J Mol Diagn (2010) 0.88
Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNA. Eur J Clin Microbiol Infect Dis (2011) 0.87
Assessment of accuracy of identification of pathogenic yeasts in microbiology laboratories in the United kingdom. J Clin Microbiol (2012) 0.82
Candida bracarensis bloodstream infection in an immunocompromised patient. J Clin Microbiol (2010) 0.82
First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes. Mem Inst Oswaldo Cruz (2016) 0.81
Candida nivariensis isolated from a renal transplant patient with persistent candiduria-Molecular identification using ITS PCR and MALDI-TOF. Med Mycol Case Rep (2013) 0.78
Digestive fungal flora in asymptomatic subjects in Bobo-Dioulasso, Burkina Faso. Asian Pac J Trop Biomed (2014) 0.75
Identification and Antifungal Susceptibility Profiles of Candida nivariensis and Candida bracarensis in a Multi-Center Chinese Collection of Yeasts. Front Microbiol (2017) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci (1996) 56.57
Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev (2001) 4.49
Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol (2005) 3.93
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis (1998) 2.94
Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis (2000) 2.59
Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol (2005) 2.52
Emerging fungal diseases. Clin Infect Dis (2005) 2.03
Biogeography of the yeasts of ephemeral flowers and their insects. FEMS Yeast Res (2001) 1.84
Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. Curr Drug Targets (2006) 1.63
Evaluation of the AUXACOLOR system, a new method of clinical yeast identification. J Clin Pathol (1995) 1.51
Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United kingdom mycology reference laboratory. J Clin Microbiol (2007) 1.47
Shifting patterns in the epidemiology of nosocomial Candida infections. Chest (2003) 1.46
Ultra-rapid preparation of total genomic DNA from isolates of yeast and mould using Whatman FTA filter paper technology - a reusable DNA archiving system. Med Mycol (2006) 1.34
Nosocomial Candida. Epidemiology, transmission, and prevention. Infect Dis Clin North Am (1997) 1.33
PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast. J Clin Microbiol (2005) 1.25
Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens. J Clin Microbiol (1999) 1.21
Invasive Candida infections: the changing epidemiology. Oncology (Williston Park) (2004) 1.19
Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin Infect Dis (1994) 1.19
The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis (2006) 3.46
A plasmid-based reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe (2007) 2.48
Functional plasticity in the type IV secretion system of Helicobacter pylori. PLoS Pathog (2013) 1.84
Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface. PLoS Pathog (2011) 1.67
Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol (2005) 1.66
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother (2013) 1.63
Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United kingdom mycology reference laboratory. J Clin Microbiol (2007) 1.47
Junctional adhesion molecule a serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J Virol (2005) 1.43
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis (2011) 1.42
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med (2008) 1.38
Ultra-rapid preparation of total genomic DNA from isolates of yeast and mould using Whatman FTA filter paper technology - a reusable DNA archiving system. Med Mycol (2006) 1.34
Molecular identification of pathogenic fungi. J Antimicrob Chemother (2008) 1.27
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis. J Clin Microbiol (2012) 1.23
Polycytella hominis is a mutated form of Scedosporium apiospermum. Med Mycol (2006) 1.22
NPXY motifs in the beta1 integrin cytoplasmic tail are required for functional reovirus entry. J Virol (2008) 1.18
A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J Mol Diagn (2006) 1.16
Microorganisms in the atmosphere over Antarctica. FEMS Microbiol Ecol (2009) 1.12
Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades. Med Mycol (2007) 1.10
Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. Med Mycol (2010) 1.06
Rapid molecular identification of pathogenic yeasts by pyrosequencing analysis of 35 nucleotides of internal transcribed spacer 2. J Clin Microbiol (2010) 1.02
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment. Intensive Care Med (2008) 0.98
An improved protocol for the preparation of total genomic DNA from isolates of yeast and mould using Whatman FTA filter papers. Mycopathologia (2010) 0.98
Sebacinales are associates of the leafy liverwort Lophozia excisa in the southern maritime Antarctic. Mycorrhiza (2009) 0.95
Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis. J Clin Microbiol (2009) 0.95
Minimal influence of water and nutrient content on the bacterial community composition of a maritime Antarctic soil. Microbiol Res (2009) 0.93
Adiaspiromycosis due to Emmonsia crescens is widespread in native British mammals. Mycopathologia (2009) 0.92
Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom. J Clin Microbiol (2013) 0.92
Dihydroisocoumarins and a tetralone from Cytospora eucalypticola. Phytochemistry (2003) 0.87
Mixed Candida albicans strain populations in colonized and infected mucosal tissues. FEMS Yeast Res (2008) 0.85
Evaluation of the viability of pathogenic filamentous fungi after prolonged storage in sterile water and review of recent published studies on storage methods. Mycopathologia (2006) 0.83
Variation at the major histocompatibility complex in Savannah sparrows. Mol Ecol (2002) 0.83
Emmonsia crescens infection in a British water vole (Arvicola terrestris). Med Mycol (2006) 0.82
Assessment of accuracy of identification of pathogenic yeasts in microbiology laboratories in the United kingdom. J Clin Microbiol (2012) 0.82
Infection of the subcutis of the nose in a cat caused by Mucor species: successful treatment using posaconazole. J Feline Med Surg (2008) 0.81
Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin. J Med Microbiol (2012) 0.81
Arthroderma olidum, sp. nov. A new addition to the Trichophyton terrestre complex. Med Mycol (2006) 0.79
Intra-aortic balloon pump inserted through the subclavian artery: A minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. J Thorac Cardiovasc Surg (2012) 0.78
Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. Med Mycol (2017) 0.78
Alternaria species infection in nine domestic cats. J Feline Med Surg (2008) 0.77
Phenotypic plasticity and evolutionary potential in somatic cells of Armillaria gallica. Mycol Res (2003) 0.76
Eumycetoma of the hand caused by Leptosphaeria tompkinsii and refractory to medical therapy with voriconazole. Mycopathologia (2011) 0.76
Transapical approach for mitral valve repair during insertion of a left ventricular assist device. ScientificWorldJournal (2013) 0.76
From the patient to the clinical mycology laboratory: how can we optimise microscopy and culture methods for mould identification? J Clin Pathol (2012) 0.75
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris. Emerg Infect Dis (2017) 0.75
House calls to Cardinal Jackson. Second Opin (1992) 0.75
Rapid methods for the extraction and archiving of molecular grade fungal genomic DNA. Methods Mol Biol (2013) 0.75
Evaluation of the commercial rapid trehalose test (GLABRATA RTT) for the point of isolation identification of Candida glabrata isolates in primary cultures. Mycopathologia (2012) 0.75
Prophylactic Subclavian Artery Intraaortic Balloon Counter-Pulsation is Safe in High-Risk Cardiac Surgery Patients. ASAIO J (2015) 0.75
First report of fatal human infections with the cactophilic yeast Sporopachydermia cereana. J Infect (2011) 0.75